Skip to main content
. 2023 Aug 8;57(6):1260–1268. doi: 10.1007/s43441-023-00559-5

Box 3.

IDI Participants’ Locations and Perspective Areas

Regulatory authorities
 South American
 European
 European
 North American
 Africa
Public health agencies
 Latin America/Caribbean
 Global Public Health Agency
Patient advocacy
 International Patients Advocacy Group
Industry
 European Industry/Drug Company
 North American Industry/Generic Drug Companies’ Representative